# Beam Therapeutics (BEAM) — Analyst Forecast

BEAM · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/beam/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 14 | 2 | 0 | 16 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 15, 2026 | HC Wainwright & Co. | Maintained | Buy | $80.00 |
| Oct 14, 2026 | Wedbush | Maintained | Outperform | $65.00 |
| Sep 9, 2026 | Wedbush | Maintained | Outperform | $65.00 |
| Aug 25, 2026 | HC Wainwright & Co. | Maintained | Buy | $80.00 |
| Jul 8, 2026 | B of A Securities | Maintained | Buy | $47.00 |
| Jul 7, 2026 | HC Wainwright & Co. | Maintained | Buy | $80.00 |
| May 13, 2026 | Bernstein | Maintained | Outperform | $39.00 |
| Mar 26, 2026 | Citigroup | Maintained | Buy | $68.00 |
| Feb 25, 2026 | Wedbush | Maintained | Outperform | $65.00 |
| Feb 25, 2026 | RBC Capital | Maintained | Sector Perform | $26.00 |
| Feb 20, 2026 | Canaccord Genuity | Initiated Coverage | Buy | $74.00 |
| Jan 21, 2026 | Bernstein | Maintained | Outperform | $41.00 |
| Jan 7, 2026 | UBS | Initiated Coverage | Neutral | $28.00 |
| Nov 24, 2025 | Evercore ISI Group | Initiated Coverage | Outperform | $35.00 |
| Oct 10, 2025 | HC Wainwright & Co. | Maintained | Buy | $80.00 |
| Oct 9, 2025 | JP Morgan | Maintained | Overweight | $46.00 |
| Sep 15, 2025 | HC Wainwright & Co. | Maintained | Buy | $80.00 |
| Aug 6, 2025 | Barclays | Maintained | Equal-Weight | $21.00 |
| May 7, 2025 | Barclays | Maintained | Equal-Weight | $25.00 |
| May 7, 2025 | Wells Fargo | Maintained | Overweight | $70.00 |

## Frequently Asked Questions

### Is BEAM a buy, sell, or hold?

Analysts covering Beam Therapeutics currently average a Buy rating: 14 buy, 2 hold and 0 sell, from 16 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on BEAM?

On Oct 15, 2026, HC Wainwright & Co. maintained Beam Therapeutics at Buy with a price target of $80.00.

## Similar Stocks

- [CRSP](https://www.lighthorse.io/tickers/crsp) — CRISPR Therapeutics AG - Common Shares
- [NTLA](https://www.lighthorse.io/tickers/ntla) — Intellia Therapeutics, Inc. - Common Stock
- [EDIT](https://www.lighthorse.io/tickers/edit) — Editas Medicine, Inc. - Common Stock
- [DNLI](https://www.lighthorse.io/tickers/dnli) — Denali Therapeutics Inc. - Common Stock
- [PRME](https://www.lighthorse.io/tickers/prme) — Prime Medicine, Inc. - Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).